0001209191-18-013400.txt : 20180226
0001209191-18-013400.hdr.sgml : 20180226
20180226164546
ACCESSION NUMBER: 0001209191-18-013400
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180222
FILED AS OF DATE: 20180226
DATE AS OF CHANGE: 20180226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hoerter Steven L.
CENTRAL INDEX KEY: 0001533451
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36014
FILM NUMBER: 18641222
MAIL ADDRESS:
STREET 1: 2525 28TH STREET, SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AGIOS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001439222
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 88 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-649-8600
MAIL ADDRESS:
STREET 1: 88 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-02-22
0
0001439222
AGIOS PHARMACEUTICALS INC
AGIO
0001533451
Hoerter Steven L.
C/O AGIOS PHARMACEUTICALS
88 SIDNEY STREET
CAMBRIDGE
MA
02139
0
1
0
0
Chief Commercial Officer
Common stock
2018-02-22
4
M
0
2050
39.76
A
2050
D
Common stock
2018-02-22
4
S
0
2050
78.63
D
0
D
Stock option (right to buy)
39.76
2018-02-22
4
M
0
2050
0.00
D
2026-02-15
Common stock
2050
72950
D
This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
This option was granted on February 16, 2016. The shares underlying this option vest as to 25% of the underlying shares on February 16, 2017, with the remaining 75% vesting in 36 equal monthly installments thereafter.
/s/ William Cook, as Attorney in Fact for Steven L. Hoerter
2018-02-26